Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry

Abstract

Autosomal dominant hyper-IgE syndrome (AD-HIES) is a rare condition. Data from the USIDNET Registry provide a resource to examine the characteristics of patients with rare immune deficiency diseases. A query was submitted to the USIDNET requesting deidentified data for patients with physician-diagnosed AD-HIES through July2016. Data on 85 patients diagnosed with AD-HIES (50 males; 35 females) born between 1950 and 2013, collected by 14 physicians from 25 states and Quebec, were entered into the USIDNET Registry by July 2016. Cumulative follow-up was 2157 years. Of these patients, 45.9% had a family history of HIES. The complications reported included skin abscesses (74.4%), eczema (57.7%), retained primary teeth (41.4%), fractures (39%), scoliosis (34.1%), and cancer (7%). Reported allergic diseases included food (37.8%), environmental (18%), and drugs (42.7%). The mean serum IgE level was 8383.7 kU/mL and was inversely correlated to the patient's age. A total of 49.4% had eosinophilia; 56% were known to be on trimethoprim-sulfamethoxazole, 26.6% on antifungal coverage, and 30.6% on immunoglobulin replacement therapy. Pneumonias were more commonly attributed to Staphylococcus aureus (55.3%) or Aspergillus fumigatus (22.4%); 19.5% had a history of lung abscess; these were most often associated with Pseudomonas aeruginosa (P Fisher's exact test= .029) or A.fumigatus (P Fisher's exact test= .016). Lung abscesses were significantly associated with drug reactions (P χ2= .01; odds ratio: 4.03 [1.2-12.97]), depression (P Fisher's exact test= .036), and lower Karnofsky index scores (P Mann-Whitney= .007). Data from the USIDNET Registry summarize the currently reported clinical characteristics of a large cohort of subjects with AD-HIES.